The blue-chip FTSE 100 was down 0.5 per cent following its strongest two-day percentage gain in two weeks on Wednesday. — Reuters pic
The blue-chip FTSE 100 was down 0.5 per cent following its strongest two-day percentage gain in two weeks on Wednesday. AstraZeneca weighed the most, down 2.2 per cent. The European Commission is in advanced deal talks with Johnson & Johnson on its Covid-19 vaccine under development, sources told Reuters.
The mid-cap FTSE 250 fell 0.4 per cent, with real estate , consumer stocks and mining and metal stocks leading declines.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
European stocks ease as BoE to unveil more stimulus | Malay MailLONDON, June 18 — European stock markets eased today after recent gains, with the Bank of England set to unveil more massive cash stimulus for Britain’s virus-hit economy. Earlier, Asian equity indices closed mixed after a two-day rally, with traders weighing concerns about a new wave of...
La source: malaymail - 🏆 1. / 86 Lire la suite »
European stocks ease as BoE to unveil more stimulus | Malay MailLONDON, June 18 — European stock markets eased today after recent gains, with the Bank of England set to unveil more massive cash stimulus for Britain’s virus-hit economy. Earlier, Asian equity indices closed mixed after a two-day rally, with traders weighing concerns about a new wave of...
La source: malaymail - 🏆 1. / 86 Lire la suite »